Global Equine Veterinary Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Equine Veterinary Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Equine Veterinary Therapeutics refers to the specialized field of veterinary medicine that focuses on the diagnosis, treatment, and management of health issues and injuries in horses. This branch of veterinary science encompasses a wide range of therapeutic interventions, including medical, surgical, and rehabilitative approaches, all aimed at maintaining the health, well-being, and performance of equines. Equine veterinary therapeutics play a crucial role in ensuring the overall health and longevity of horses, whether they are involved in sports and competition or serve as companion animals.
Global Equine Veterinary Therapeutics market is projected to reach US$ 2044.9 million in 2029, increasing from US$ 1258 million in 2022, with the CAGR of 6.8% during the period of 2024 to 2029. Demand from Veterinary Hospital and Veterinary Clinics are the major drivers for the industry.
A significant driver in the Equine Veterinary Therapeutics market is the growing demand for high-quality healthcare and treatment options for horses. As the importance of equines in various sectors, including sports, agriculture, and leisure, continues to rise, there is an increased emphasis on maintaining their health and performance. This drives the demand for innovative veterinary therapeutics, such as advanced medications, surgical techniques, and rehabilitation methods, to address a wide range of equine health issues. One of the key challenges in this market is the cost associated with advanced equine veterinary care. High-end treatments, specialized surgeries, and cutting-edge therapies can be expensive, which may limit access for some horse owners or require substantial investments. Additionally, ensuring the safety and effectiveness of equine therapeutics can be challenging due to the size and unique physiology of horses, requiring specialized expertise and equipment. Regulatory compliance and ensuring the welfare of the animals also pose ongoing challenges in this industry.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Equine Veterinary Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Boehringer Ingelheim
Merck Animal Health
Zoetis
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Segment by Type
Drugs
Vaccine
Other
Veterinary Hospital
Veterinary Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Equine Veterinary Therapeutics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Equine Veterinary Therapeutics introduction, etc. Equine Veterinary Therapeutics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Equine Veterinary Therapeutics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Global Equine Veterinary Therapeutics market is projected to reach US$ 2044.9 million in 2029, increasing from US$ 1258 million in 2022, with the CAGR of 6.8% during the period of 2024 to 2029. Demand from Veterinary Hospital and Veterinary Clinics are the major drivers for the industry.
A significant driver in the Equine Veterinary Therapeutics market is the growing demand for high-quality healthcare and treatment options for horses. As the importance of equines in various sectors, including sports, agriculture, and leisure, continues to rise, there is an increased emphasis on maintaining their health and performance. This drives the demand for innovative veterinary therapeutics, such as advanced medications, surgical techniques, and rehabilitation methods, to address a wide range of equine health issues. One of the key challenges in this market is the cost associated with advanced equine veterinary care. High-end treatments, specialized surgeries, and cutting-edge therapies can be expensive, which may limit access for some horse owners or require substantial investments. Additionally, ensuring the safety and effectiveness of equine therapeutics can be challenging due to the size and unique physiology of horses, requiring specialized expertise and equipment. Regulatory compliance and ensuring the welfare of the animals also pose ongoing challenges in this industry.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Equine Veterinary Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Boehringer Ingelheim
Merck Animal Health
Zoetis
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Segment by Type
Drugs
Vaccine
Other
Segment by Application
Veterinary Hospital
Veterinary Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Equine Veterinary Therapeutics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Equine Veterinary Therapeutics introduction, etc. Equine Veterinary Therapeutics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Equine Veterinary Therapeutics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices